xPharm: The Comprehensive Pharmacology Reference 2008
DOI: 10.1016/b978-008055232-3.61156-0
|View full text |Cite
|
Sign up to set email alerts
|

Acenocoumarol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 52 publications
0
0
0
Order By: Relevance
“…These limitations of VKAs have led to the development of new oral anticoagulants, as found by Head SJ et al [ 2 ]. Compared to warfarin, acenocoumarol has advantages such as a faster onset of action, less enzymatic metabolism by CYP2C9, more stable anticoagulation, and better reversal of anticoagulant action [ 3 ]. In India, acenocoumarol (Acitrom) is a popular choice for oral anticoagulant therapy in major cardiac surgeries [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…These limitations of VKAs have led to the development of new oral anticoagulants, as found by Head SJ et al [ 2 ]. Compared to warfarin, acenocoumarol has advantages such as a faster onset of action, less enzymatic metabolism by CYP2C9, more stable anticoagulation, and better reversal of anticoagulant action [ 3 ]. In India, acenocoumarol (Acitrom) is a popular choice for oral anticoagulant therapy in major cardiac surgeries [ 4 ].…”
Section: Introductionmentioning
confidence: 99%